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An Omics Perspective on Candida
Infections: Toward Next-Generation
Diagnosis and Therapy
S. P. Smeekens, F. L. van de Veerdonk and M. G. Netea*
Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands
Candida species can cause severe infections associated with high morbidity and
mortality. Therefore, it is essential to gain more insight into the anti-fungal host
defense response. The advent of omics technology and development of advanced
systems biology tools has permitted to approach this in an unbiased and quantitative
manner. This review summarizes the insights gained on anti-Candida immunity from
genetic-, transcriptome-, proteome-, metabolome-, microbiome-, mycobiome-, and
computational systems biology studies and discusses practical aspects and future
perspectives.
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INTRODUCTION
Candida albicans is an opportunistic fungal microorganism which resides in the gastro-intestinal
tract in healthy persons (Gouba and Drancourt, 2015). However, in some individuals colonization
may lead to invasion and clinical disease: 75% of all woman experience vulvovaginal candidiasis at
least once in there lifetime, and up to 5% of woman suﬀer from recurrent vulvovaginal candidiasis
(Sobel, 1988). Furthermore, when the immune system is weakened, as in immunocompromised
hosts (Wingard, 1979), Candida species can cause severe skin-, mucosal- and even systemic
infections. In this respect, Candida is the fourth most common etiologic agent of sepsis in US
hospitals, with 9.0% of all nosocomial blood stream infections being caused by Candida species.
Despite current treatment strategies, the crude mortality rate associated with candidiasis remains
very high at 39.2% (47.1% in intensive care unit patients and 27.0% in patients from other wards).
For some Candida species (C. krusei) the crude mortality rate even reaches 58.7% (Wisplinghoﬀ
et al., 2004).
While the current knowledge of the host defense against C. albicans, mostly derived from
classical immunological studies, has recently been reviewed (Netea et al., 2015), and the
pathogenesis, diagnosis and treatment of invasive candidiasis has been recently described by
Kullberg and Arendrup (2015), in the present review we will discuss the novel approaches to
understand pathophysiology of Candida infections that make use of the novel omics technologies.
Abbreviations: Alb, albumin; CD, cluster of diﬀerentiation; CMC, chronic mucocutaneous candidiasis; CXCL, chemokine
(C-X-C motif) ligand; Eno, enolase; GWAS, genome wide association study; Hap, hook-associated protein; Hsp, heat
shock protease protein; IFIH, interferon induced with helicase c domain; IL, interleukin; LCE, late corniﬁed envelope;
Mta, metastasis-associated protein; NF, nuclear factor; OR, odds ratio; PHI, pathogen-host interaction; Ptx, pentraxin; MIP,
macrophage inﬂammatory protein; PBMC, peripheral blood mononuclear Cells; RGS, regulator of G-protein signaling;
SHIP, SH2 domain containing inositol phosphatase; SNP, single nucleotide polymorphism; TAGAP, T cell activation
RHO-GTPase-activating protein; TNF, tumor necrosis factor; TNFRSF, tumor necrosis factor super family.
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RATIONALE
Despite current treatment regimens, systems fungal infections
are still associated with high morbidity and mortality. In order
to develop novel treatment strategies it is crucial to gain more
insight into the host response against these infections. In the past,
antifungal host defense research was based on hypothesis-driven
in vitro or experimental studies. Although these “classical” studies
can validate the importance of certain aspects of antifungal
defense, they have a slow progress toward providing novel
insights, and they are often poor indicators of the relative
importance of certain pathways, both of which are crucial when
looking for novel therapy targets. In this review we will focus on
systems biology research that has been performed on the (human)
host defense against fungal infections. Many studies have been
performed on the omics of the fungal pathogen itself, but these
lie beyond the scope of this review (see other reviews: e.g., Horn
et al., 2012).
Genomics
Relatively much research has been performed on the genetic
susceptibility to Candida diseases. A recent review summarizes
these ﬁndings; many of the genetic variants contributing to
Candida susceptibility are located in pathogen recognition-
or cytokine receptors and downstream signaling molecules
(Smeekens et al., 2013c). Recently, Kumar et al. (2014) published
the ﬁrst GWAS on a fungal infection. The authors analyzed
118,989 single-nucleotide polymorphisms (SNPs) across 186 loci
known to be associated with immune-mediated diseases in a
cohort of 217 systemic candidemia patients and 11,920 controls.
There was a signiﬁcant association between candidemia and
SNPs in CD 58 (OR = 4.68), LCE4A (LCE 4A; OR = 4.25)
and TAGAP (OR = 2.96) loci. The combination of two or more
risk alleles even gave an increased risk for candidemia of 19.4-
fold compared to no risk allele (Kumar et al., 2014). CD58, and
adhesion molecule on antigen presenting cells, appeared to be
involved in the inhibition of Candida germination. TAGAP on
the other hand was needed for optimal Candida-induced TNF-
α production, as shown by experiments performed in Tagap−/−
mice.
Transcriptomics
Barker et al. (2005) published a study on the transcriptional
response of THP-1 cells after 3 h of stimulation with live
C. albicans SC5314. TNFA, IL8, CD83, MIP1A, and MIP1B were
among the genes up-regulated for at least twofold, whereas CCR2
and NCF2 were down-regulated. A novel ﬁnding was the up-
regulation of RGS1, RGS2, RGS16, down syndrome critical region
1, CXCL2, early growth response 3, FLT4, and TNF-α-induced
protein 6, as these genes were not previously known to be
responsive to C. albicans (Sobel, 1988; Barker et al., 2005).
In 2008, the authors published a similar study on vascular
endothelial cells, which responded quite diﬀerently on Candida
stimulation; genes in chemotaxis, angiogenesis and inhibition of
apoptosis weremostly up-regulated in endothelial cells (Wingard,
1979; Barker et al., 2008). Also in human umbilical vein
endothelial cell lines C. albicans induced diﬀerential expression
of genes involved in apoptosis and cell death (Wisplinghoﬀ
et al., 2004; Muller et al., 2007; Li et al., 2011). Apparently
the cell type under investigation has great inﬂuence on the
resulting transcriptional proﬁle after Candida stimulation; In
human epithelial cells stimulation with C. albicans causes an
up-regulation of genes from the NF-κB, mitogen-activated
protein kinase and phosphoinositide 3 kinase/protein kinase
B immune signaling pathways (Moyes et al., 2014; Netea
et al., 2015), and of chemokines and adhesion molecules (Ikuta
et al., 2012; Kullberg and Arendrup, 2015). On the other
hand, in human granulocytes (neutrophils) C. albicans induces
transcription of genes involved in cell-cell signaling, cell signal
transduction and cell growth (Fradin et al., 2007; Horn et al.,
2012).
In contrast, some stimuli induce such a strong eﬀect that this
can be observed in multiple species and cell types. In the murine
macrophage cell line J774.2, C. parapsilosis induces transcription
of genes from stress-, inﬂammation-, chemokine-, and cytokine
pathways. The highest diﬀerential expression was seen with
the TNFRSF9 gene, which was 39-fold increased after 8 h of
stimulation. Also in peritoneal macrophages from Bagg albino/c
mice and in human PBMC-derived macrophages TNFRSF9 was
strongly up-regulated after C. parapsilosis stimulation (Kumar
et al., 2014; Németh et al., 2014).
Transcriptomic studies on the pathogen side can also throw a
light upon the reaction of the host immune system to the fungus.
In order to do this, Fradin et al. (2005) exposed C. albicans to
diﬀerent blood fractions. C. albicans thrives in the absence of
neutrophils. In contrast, in the presence of neutrophils C. albicans
increases responses to overcome nitrogen- and carbohydrate
starvation and genes involved in the oxidative stress response
are upregulated. These results suggest that neutrophils play an
essential role in the defense against C. albicans (Fradin et al.,
2005).
Transcriptomics cannot only be used to learn new things
about the host immune response, it might also be used as a
diagnostic tool; in a murine infection model candidemia could
accurately be classiﬁed and distinguished from Staphylococcus
aureus infection with a sensitivity and speciﬁcity of 98 and
96%, respectively. Furthermore, by looking at the transcription
proﬁle, also infection progression could be accurately predicted;
day one after infection there is increased expression of CXCL2,
CXCL13, and IL10R; day two after infection there is increased
expression of genes in the TNF-NFκB-B-cell lymphoma 2
pathway; whereas at day three and four, there is down-
regulation of apoptotic genes but up-regulation of genes in
Toll-like receptor pathways, inﬂammatory cytokines, of genes
involved in NFκB-dependent and mitogen-activated protein
kinase-dependent signaling cascades, and of genes involved in
T cell activation (Zaas et al., 2010). Also in human blood, the
transcriptional proﬁle after bacterial stimulation (S. aureus and
Escherichia coli) could be distinguished from that after fungal
stimulation (C. albicans and Aspergillus fumigatus) using random
forest classiﬁcation (Dix et al., 2015). This information might
be useful in sepsis, where early knowledge on the nature of
the causative agent is crucial for selecting the appropriate anti-
microbial therapy.
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Another transcriptome study indicating the possibility to use
transcriptomics as discovery tool was published in 2013. Candida
infection could be discriminated from bacterial infection based
on a 101-transcript feature set from in vitro experiments with
human PBMC. Interestingly, in this set of 101 genes, genes from
the type I interferon pathway were signiﬁcantly overrepresented.
This was unexpected as type I interferons had previously
been associated with viral and bacterial infections. However,
these ﬁndings were validated on a functional level in humans
(Smeekens et al., 2013b), and also in independent mice studies
(Majer et al., 2012; del Fresno et al., 2013). In a separate
transcriptome experiment in humans, IFIH1, also part of the type
I interferon signaling pathway, was implicated in the host defense
against C. albicans hyphae. This ﬁnding was also validated on a
functional level; patients with CMC express lower levels of IFIH1,
there is a strong correlation between genetic variation in IFIH1
and candidemia, and cells from IFIH1 knock out mice and PBMC
with diﬀerent IFIH1 genotypes have altered cytokine production
upon C. albicans stimulation (Jaeger et al., 2015).
Tierney et al. (2012) studied the transcriptional proﬁle of
C. albicans and mouse dendritic cells simultaneously. Mouse
Ptx3 can bind to the C. albicans cell wall, and thereby regulates
the transcription of fungal Hap3 target genes, this again alters
the immune response to C. albicans, through altered expression
of mouse Mta2 target genes like IL-2 and IL-4 (Tierney et al.,
2012). Schulze et al. (2015) described a network inference tool
(NetGenerator), which constructs gene regulatory networks from
time series gene expression data. They re-analyzed the Tierney
dataset, taking into account variances in replicated measurement
data. Again, the inter-species interactions between Ptx3, Hap3,
and Mta2 were considered robust (Schulze et al., 2015). These
studies emphasize the need to take into account the fact that there
is an interaction between the host and pathogen.
Proteomics
Although studies using transcriptomics are a very insightful tool,
they are not able to mirror fully the landscape of active molecules
inside an organism; therefore systemic assessment of proteins is
an important step for understanding fungal-immune interaction.
Since the introduction of proteomics, this can be done in a
systematic manner. When the murine macrophage RAW 264.7
cell line was exposed to live C. albicans SC5314, the regulation
of several proteins was aﬀected; annexin I, LyGDI, Hspa5,
tropomyosin 5, and L-plastin were increased while eukaryotic
translation initiation factor 3 subunit 5, Hsp 60, Hspa9a,
glucose-regulated protein 58, and Hspa8a were decreased. This
indicates that several processes are aﬀected including cytoskeletal
organization, oxidative responses and protein biosynthesis and
refolding (Martínez-Solano et al., 2006). In contrast, when
murine macrophages are stimulated with heat-killed C. albicans
the overall response is more anti-inﬂammatory, although there
are some similarities with live C. albicans stimulation as well
(Martinez-Solano et al., 2009).
Upon separately analyzing cytosol, organelle/membrane and
nucleus enriched fractions from C. albicans-stimulated RAW
264.7 macrophages, 17 new diﬀerentially expressed proteins
were identiﬁed. These proteins are involved in pro-inﬂammatory
and oxidative responses, immune response, unfolded protein
response and apoptosis (Reales-Calderón et al., 2012). Also the
amount of the membrane receptor Galactin-3, a lectin receptor
that recognizes b-mannans (Jouault et al., 2006), was increased
upon C. albicans stimulation, especially in phagocytic cups
(Reales-Calderón et al., 2012). This receptor had previously been
implicated in the pathophysiology of infection by a transcriptome
study in mouse macrophages infected with C. albicans, where
a 3.4-fold up-regulation of galectin-3 was observed (Shin et al.,
2006).
The ﬁrst proteomics study in human cells stimulated with
Candida was published in 2014. The diﬀerences in proteomes
between human M1 and M2 macrophages were studied upon
stimulation with C. albicans. The biggest diﬀerences were found
in cytoskeletal rearrangement and metabolic routes; fructose-
1,6-biphosphatase 1, a glycogenesis enzyme, is up-regulated in
M1 macrophages. Interestingly, stimulation with C. albicans has
been suggested to induce a polarization switch from M1 to
M2, although one could argue that there is no full correlation
between cellular markers and the function of the cell. This
switch could be interpreted either as an attempt of the host to
reduce damage caused by inﬂammation, or it could be a Candida
pathogenicity mechanism by decreasing the immune response
(Reales-Calderón et al., 2014).
Proteomics can also be applied to the in vivo situation;
in human cervical-vaginal ﬂuids almost half of the proteins
are plasma components. The presence of Alb, transferrin,
immunoglobulins, apolipoproteins, alpha-1-acid glycoprotein 1
and calgranulins is positively correlated with the amount of
polymorphonuclear leukocytes, but there is no diﬀerence in the
protein maps of asymptomatic women and women experiencing
vulvovaginal candidiasis (Tang et al., 2007). In contrast, in non-
neutropenic patients, invasive candidiasis could be predicted by
measuring their serum antibody signature against the C. albicans
proteins Hsp90 and Eno1 prospectively (Pitarch et al., 2014).
Proteomics can be used to investigate speciﬁc proteins.
Dectin-1 is an important C-type lectin receptor in the
recognition of C. albicans, which recognizes β-1,3- and β-
1,6-glucans. In order to investigate early Dectin-1 signaling, the
interactome of the intracellular receptor tail was explored using
a pull-down proteomics approach in mouse CD11c+ cells. The
SHIP-1 colocalizes with Dectin-1 during zymosan phagocytosis,
and relocates to C. albicans-containing phagosomes. Further
experiments with SHIP-1 deﬁcient granulocyte-macrophage
colony-stimulating factor-derived bone marrow cells
demonstrated an important role for SHIP-1 in the regulation
of reactive oxygen species production (Blanco-Menendez et al.,
2015).
Metabolomics
Metabolome studies in individuals with Candida infections are
scarce. There is one study in which the urine metabolic proﬁle
was compared between a preterm neonate with C. parapsilosis
infection and 13 preterm controls. N-glycine, D-serine, L-
threonine, D-glucose, and maltose levels are higher in urine
during C. parapsilosis infection, whereas citric acid, hexadecanoic
acid and octadecanoic acid are decreased. Interestingly, therapy
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eﬃcacy can be evaluated based on the metabolic proﬁle (Dessì
et al., 2014).
Microbiome
Several studies suggest that the microbiome composition has an
important impact on health status (Pﬂughoeft and Versalovic,
2012). The microbiome composition can be inﬂuenced by diet. In
a mice study, dietary coconut oil reduced C. albicans colonization
of the gastro-intestinal tract (Gunsalus et al., 2015). Candida
colonization is also inﬂuenced by quantitative and qualitative
aspects of the microbiome. Kennedy and Volz (1985) described
that Lactobacilli inhibit fungal adhesion and growth by producing
H2O2 and bacteriocin-like compounds. Also short-chain fatty
acids from Lactobacilli can inhibit fungal growth (Noverr and
Huﬀnagle, 2004). Furthermore, Pseudomonas aeruginosa and
Enterococcus faecalis can inhibit C. albicans hyphae formation
(Hogan et al., 2004). Also in a Caenorhabditis elegans model,
E. faecalis inhibits C. albicans hyphal morphogenesis (Cruz et al.,
2013). On the other hand, C. albicans can coaggregate with
Streptococci, which may facilitate the colonization of oral surfaces
by the yeast (Jenkinson et al., 1990).
Not only can the microbiome composition inﬂuence the
extent of Candida colonization, it can also inﬂuence the
immune response against Candida species (Kolwijck and van de
Veerdonk, 2014; Oever and Netea, 2014; Romani et al., 2014).
Mice treated with the short-chain fatty acid propionate, which
also increases after the consumption of dietary fermentable ﬁbers,
have enhanced generation of macrophage and dendritic cell
precursors, more dendritic cells in the lungs and reduced Th2
eﬀector function. This demonstrates that changes in diet and
metabolism can alter the immunological environment in the
lungs (Trompette et al., 2014).
Also in humans the microbiome composition has been
demonstrated to inﬂuence the immune response against
C. albicans; in patients with hyper IgE syndrome and CMC,
there are reduced numbers of regular skin microbiome members
(e.g., Corynebacteria), but more Gram-negative bacteria (e.g.,
Acinetobacter), of which the latter in in vitro stimulation
experiments with PBMC suppress the S. aureus and C. albicans-
induced cytokine production (Smeekens et al., 2013a). The
vaginal microbiome of patients with vulvovaginal candidiasis is
highly variable, and could not be described by any single proﬁle
(Liu et al., 2013).
How the microbiome inﬂuences the immune system is not
completely clear yet. One mechanism proposed by Zelante et al.
(2013) is that lactobacilli in the gut can use tryptophan as their
energy source and produce indole-3-aldehyde in the process.
Indole-3-aldehyde stimulates the aryl hydrocarbon receptor,
which induces IL-22 production in NKprotein46+NK1.1low cells,
that are in turn protective against Candida colonization at
mucosal surfaces (Zelante et al., 2013).
Mycobiome
Not only antifungal immunity is aﬀected by microbiome
composition; also fungal colonization can be inﬂuenced by
the host microbiome. The fungal microbiome, also known as
mycobiome, is a relatively novel research area. In terms of
abundance fungi are relatively rare on human skin (Findley
et al., 2013). However, when the normal balance is disturbed,
e.g., in immunocompromised hosts, resident fungi can expand
(Huﬀnagle and Noverr, 2013). Indeed, antibiotic treatment in
mice causes an altered gut microbiome that coincides with
outgrowth of commensal Candida species in the gut (Kim
et al., 2014). Also genetic factors contribute to mycobiome
composition; in dectin-1 deﬁcient mice there is an altered gut
mycobiome, which subsequently increases the susceptibility to
experimental colitis (Iliev et al., 2012).
Oral microbiome analysis revealed that C. albicans was the
most common fungal microorganism in healthy controls and
HIV-infected participants. Candida colonization is negatively
correlated with Pichia abundance. Pichia conditioned medium
inhibits Candida growth and bioﬁlms. Interestingly, in a
murine oral candidiasis model Pichia conditioned medium
lowers infection score, fungal burden, and tongue epithelial
damage. This study demonstrates that ﬁndings from mycobiome
data can lead to novel interesting antifungals (Zelante et al.,
2014).
Computational Systems Biology
Technical advances in the last years have increased the
availability of ‘omics’ data, thereby augmenting the demands for
mathematical modeling. As mentioned before, it is important to
consider there is an ongoing interaction between cells, proteins
and metabolites of pathogens and the host, which inﬂuences
the outcome of infection. Dühring et al. (2015) recently gave
an overview of host defense strategies and the corresponding
fungal evasion mechanisms, and the computational systems
biology approaches to investigate these interactions. Durmus˛
et al. (2015) also reviewed the available literature on the
computational analysis of PHI networks, and in addition the
use of web-based databases and text-mining tools in order to
optimize use of currently existing data. Last year, PHI networks
for C. albicans and A. fumigatus were constructed, based on
protein orthology and gene function. These networks predicted
Eno1, phospholipase B, Hsp70, pyruvate kinase (CDC19) as
Candida virulence factors, which interact with the host factors
CD4, Alb and amyloid beta (A4) precursor protein, Toll-like
receptor 2, and epidermal growth factor receptor, respectively.
These networks can serve as a framework in the analysis
of host-pathogen transcriptome and proteome data (Remmele
et al., 2015). It is also possible to incorporate the migration
of interacting immune and Candida cells in three-dimensional
space in a PHI network (Lehnert et al., 2015). Building a more
detailed and accurate PHI model may aid timely stratiﬁcation of
sepsis patients based on their inﬂammatory status in the future.
DISCUSSION
Several studies have demonstrated that Candida infection can
be discriminated from bacterial infection based on the induced
transcriptome proﬁle (Zaas et al., 2010; Smeekens et al., 2013b),
suggesting that in the future transcriptomics might be used
in diagnostics. However, these results should be replicated
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FIGURE 1 | Overview of omics tools used in studies on the anti-Candida host defense. Host genetic-, transcriptome-, proteome-, metabolome-,
microbiome-, and mycobiome data have been linked to immunity/host defense. Host genetic factors play to a lesser extent a role in consecutively transcriptome,
proteome, metabolome, and microbiome and mycobiome data.
TABLE 1 | Research highlights from functional genomics studies on the host immune response against Candida albicans
Tool Model Main findings Reference
Genomics GWAS with human candidemia
patients
SNPs in CD58, LCE4A, TAGAP increase risk for
candidemia
Kumar et al., 2014
Transcriptomics In vitro studies with human
monocyte cell line or mouse
dendritic cells
Differential expression of specific genes: RGS1,
RGS2, RGS16, down syndrome critical region 1,
CXCL2, early growth response 3, FLT4,
TNF-α-induced protein 6, Ptx3, and Mta2
Barker et al., 2005; Tierney et al.,
2012; Schulze et al., 2015
Endothelial cells stimulated with
C. albicans
Differential regulation of certain pathways: Type I
interferons; chemotaxis, angiogenesis, apoptosis,
cell death, NF-κB- MAPK- and PI3K/Akt signaling;
cell–cell signaling, cell signal transduction and cell
growth, chemokines and adhesion molecules
Wisplinghoff et al., 2004; Fradin
et al., 2007; Muller et al., 2007;
Barker et al., 2008; Li et al., 2011;
Horn et al., 2012; Ikuta et al., 2012;
Smeekens et al., 2013b; Moyes
et al., 2014; Kullberg and Arendrup,
2015; Netea et al., 2015
Murine candidemia model,
in vitro studies with human
blood
Transcriptomics can be used as a diagnostic tool to
discriminate fungal from bacterial infection
Zaas et al., 2010; Dix et al., 2015
Proteomics Serum from non-neutropenic
patients
Proteomics can be useful in prognosis: the serum
antibody signature against the C. albicans proteins
Hsp90 and Eno1 is predictive of invasive
candidiasis
Pitarch et al., 2014
In vitro studies with human and
murine macrophages
Differential regulation of certain processes:
cytoskeletal organization, oxidative responses,
protein biosynthesis and refolding, pro-inflammatory
responses, immune response, unfolded protein
response and apoptosis and metabolism
Martínez-Solano et al., 2006;
Reales-Calderón et al., 2012, 2014;
Blanco-Menendez et al., 2015
Metabolomics Urine metabolome in
C. parapsilosis neonate
Increased levels of N-glycine, D-serine, L-threonine,
D-glucose and maltose levels. Decreased levels of
citric acid, hexadecanoic acid and octadecanoic
acid
Dessì et al., 2014
Microbiome In vitro experiments Microbiome composition can influence Candida
colonization
Hogan et al., 2004; Noverr and
Huffnagle, 2004
Microbiome studies in patients
with skin/mucosal C. albicans
infections, mice studies
Microbiome composition influences the host
immune response against C. albicans
Zelante et al., 2013; Smeekens
et al., 2013a; Trompette et al., 2014
Mycobiome Oral microbiome analysis in HIV
patients, in vitro studies and a
murine oral candidiasis model
Pichia inhibits C. albicans Zelante et al., 2014
Computational systems biology Construction of PHI network The host factors CD4, Alb and amyloid beta (A4)
precursor protein, Toll-like receptor 2, epidermal
growth factor receptor are predicted to interact with
C. albicans virulence factors
Remmele et al., 2015
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ﬁrst in independent studies. This will be challenging because
it is diﬃcult to recruit large cohorts of candidemia patients.
Furthermore, transcriptome studies are fairly costly and time-
consuming, while rapid diagnostics are desirable. Moreover,
analysis of transcriptome data is not straightforward and should
be standardized between the studies (Jafari and Azuaje, 2006).
Still, functional genomics studies are very useful, because they
can lead to the discovery of novel therapy options. Microbiome
studies have indicated several (products of) microorganisms
that can inhibit Candida growth, like Pichia (Zelante et al.,
2014), Lactobacilli (Kennedy and Volz, 1985; Noverr and
Huﬀnagle, 2004; Zelante et al., 2013), P. aeruginosa and
E. faecalis (Hogan et al., 2004). More research is necessary to
utilize this knowledge in the development of novel treatment
options.
There are some things to take into consideration when
conducting or analyzing functional genomics studies. First of
all, many studies do not demonstrate sample size calculations,
and cohorts are usually small, introducing the possibility of
false-positive ﬁndings and over-ﬁtting of data to the speciﬁc
cohort under investigation. Therefore, validation is an import
issue. Many ﬁndings have not been validated in independent
cohorts, making it diﬃcult to assess their value. Of course, for
in vivo studies it is diﬃcult to gather large cohorts of patients,
as invasive Candida infections are relatively scarce, especially
from an individual medical center point of view. In the urine
metabolome study there was one premature baby (32 weeks
gestational age) with a fungal chest infection, who was compared
to 13 premature healthy babies (mean gestational age 34.6). With
only one patient it is diﬃcult to discern the true eﬀect on the
metabolome of fungal infection from other (external) factors like
in this case respiratory distress and gestational age (Dessì et al.,
2014).
Next to adequate samples size and validation in independent
cohorts it is also important to keep in mind the functional
validation of novel ﬁndings. Employing systems biology will
always lead to a top list of genes, proteins, metabolites, or
microorganisms associated with a certain phenotype likeCandida
infection. However, this does not mean that these associations
are also relevant. Furthermore, it is diﬃcult to interpret
novel, unexpected ﬁndings, without knowing their functional
consequence(s). Therefore results need to be validated on a
functional level. For example, Zelante et al. (2014) demonstrated
that Candida colonization was negatively correlated with Pichia
abundance in HIV patients, which is a purely statistical ﬁnding.
They strengthened this ﬁnding by demonstrating that Pichia
conditioned medium inhibits Candida growth and bioﬁlm
formation. More importantly, Pichia conditioned medium
ameliorated a murine oral candidiasis model (Zelante et al.,
2014). Furthermore, Kumar et al. (2014) demonstrated in a
GWAS study that SNPs in CD58, LCE4A, and TAGAP were
signiﬁcantly associated with candidemia. Two of the genes
were validated on a functional level; in siRNA experiments
CD58 appeared to be involved in the inhibition of Candida
germination. Tagap−/− mice had reduced Candida-induced
TNF-α production (Kumar et al., 2014).
There is no golden standard in systems biology approaches.
The correlation between diﬀerent systems biology approaches is
not 100%; in mice it has been reported that for only about half
of the genes tested there was a correlation between transcripts
and proteins, with an average correlation of 0.27 (Ghazalpour
et al., 2011). Compared to the proteome the metabolome is even
less subject to genetic inﬂuences but more to environmental
factors (Figure 1). In a study with healthy male volunteers, up
to 12% of the observed variance in metabolite concentrations
could be explained by genetic variation in common SNPs
(Gieger et al., 2008). Although the transcriptome, proteome
and metabolome are less subject to genetic inﬂuences, they are
often more closely related to phenotypic traits compared to
genome data (Homuth et al., 2012). In contrast, clinical traits,
like adiposity, were more strongly correlated to transcript levels
than to protein levels in a study with mice (Ghazalpour et al.,
2011).
Also the models and experimental setups that are chosen
have great inﬂuence on systems biology approaches. As discussed
above, C. albicans induces the transcription of diﬀerent principal
pathways in human monocyte-like cells (Barker et al., 2005),
vascular endothelial cells (Muller et al., 2007; Barker et al., 2008;
Li et al., 2011), human epithelial cells (Ikuta et al., 2012; Moyes
et al., 2014) and human granulocytes (neutrophils; Fradin et al.,
2007). The fungal species is of importance as well, and TNFRSF9
transcription has so far only been shown to be up-regulated after
C. parapsilosis stimulation (Németh et al., 2014). Most studies
have been performed with C. albicans, while other fungal species,
like C. tropicalis, C. glabrata, and C. krusei, are also medically
relevant (Kullberg and Arendrup, 2015). These should also be
the focus of future studies. Another aspect is fungal strain and
morphology; many studies use heat-killed fungi, while these
are fundamentally diﬀerent from live fungi. In PBMC cultures
live C. albicans can actively suppress IL-17 production (Cheng
et al., 2010), and important cytokine in the anti-Candida host
defense (van de Veerdonk et al., 2009). So although using live
fungal pathogens more closely resembles an in vivo infection, it
is more diﬃcult to delineate host defense responses from fungal
inﬂuences.
In the past few years, functional genomics studies have led
to interesting novel discoveries regarding the anti-Candida host
defense (Table 1), making them a valuable addition to classical
immunological studies.
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